| Patents for C12Q 1 - Measuring or testing processes involving enzymes or micro-organisms; Compositions therefor; Processes of preparing such compositions (300,231) |
|---|
| 03/28/2000 | US6043506 Multi parameter scanner |
| 03/28/2000 | US6043347 Compositions and methods for treating viral infections |
| 03/28/2000 | US6043342 Human protein whose presence indicates ongoing neoplastic development within cells and tissues of epithelial cell origin and thus is a reliable and reproducible biochemical marker |
| 03/28/2000 | US6043340 Synthetic peptide having amino acid sequence encoded by genetic suppressor element isolated from kinesin gene; for investigating drug resistance |
| 03/28/2000 | US6043222 Two new human DnaJ-like proteins |
| 03/28/2000 | US6043093 Directing evolution of molecule into one that reacts with a recognition sequence by expression in cells containing growth factor, modulation moiety and recognition sequence; mutagenizing; replication; selecting for modified growth |
| 03/28/2000 | US6043084 Nucleotide sequences which encode a cancer associated antigen |
| 03/28/2000 | US6043073 Phospholipase D polypeptide and DNA sequences |
| 03/28/2000 | US6043071 GlmU |
| 03/28/2000 | US6043070 With specific sequence of nucleotide linkages; for nucleic acid amplification reactions such as polymerase chain reactions and nucleic acid sequencing |
| 03/28/2000 | US6043059 Performing series of reactions involving hybridizing primer to target and effecting chain extension/chain termination; using primer from presynthesized set having raised annealing temperature and/or improved annealing properties |
| 03/28/2000 | US6043056 Amino acid sequences; for diagnosis, treatment, and prevention of blood, karyotypic, and nervous system disorders |
| 03/28/2000 | US6043054 Polynucleotides encoding a novel GABA BP polypeptide |
| 03/28/2000 | US6043053 Wnt-3 polynucleotides |
| 03/28/2000 | US6043052 Nucleotide and amino acid sequences of g protein coupled receptor; for diagnosis and treatment of related diseases; anticarcinogenic/antidiabetic/antiulcer agents; antidepressants; hypotensive/hypertensive agents |
| 03/28/2000 | US6043049 Using culture receptacle having a layer of growth medium and having higher pressure in one chamber than another to allow diffusion of water in the layer of growth medium to reduce its heterogeneity |
| 03/28/2000 | US6043048 Rapid inducible beta-lactamase screen test |
| 03/28/2000 | US6043047 Sample-collecting and assay device for use in the detection of biological material |
| 03/28/2000 | US6043046 Method for detection of atopic dermatitis |
| 03/28/2000 | US6043045 Screening methods for the identification of novel antibiotics |
| 03/28/2000 | US6043044 Macrophage migration inhibitory factor as diagnostic and prognostic marker for metastatic adenocarcinoma |
| 03/28/2000 | US6043042 Antibody which binds cleavage fragment of nerve cell peptide produced by action of a toxin; for immunoassays |
| 03/28/2000 | US6043041 Amplification and detection of Shiga-like toxin II producing organisms |
| 03/28/2000 | US6043040 Csak-3 nucleic acid molecules and uses therefor |
| 03/28/2000 | US6043039 Obtaining chromosome spread, preparing composite of chromosomal paints, denaturing composite and renaturing leaving unique sequences single-stranded, hybridizing to chromosomes, washing, analyzing and presenting images |
| 03/28/2000 | US6043038 High-throughput screening assays for modulators of primase activity |
| 03/28/2000 | US6043037 Quantifying frequency of incomplete chromosome aberrations by the frequency of terminal translocations, quantifying frequency of complete chromosome aberrations, comparing to determine a signature |
| 03/28/2000 | US6043036 Producing mixtures of complementary, labeled oligonucleotides with unique two- or three-nucleotide terminators; separating each mixture by electrophoresis; independently identifying relative spacing of each mixture; analyzing patterns |
| 03/28/2000 | US6043035 Determining prothrombin level in an individual, where an elevated level is indicative of an increased risk; for screening and diagnosis of thrombophilia |
| 03/28/2000 | US6043034 Mixing sample, raman scattering active agent which binds to polynucleotide, and surface-enhanced raman scattering active substrate which bonds excess agent; irradiating; measuring radiation generated by agent captured on surface of substrate |
| 03/28/2000 | US6043031 DNA diagnostics based on mass spectrometry |
| 03/28/2000 | US6043030 Cell-cycle regulatory proteins, and uses related thereto |
| 03/28/2000 | US6043028 Method for synthesizing single-stranded stem-loop DNA's the products and uses therefore |
| 03/28/2000 | US6043024 Use of one-dimensional nuclear magnetic resonance to identify ligands to target biomolecules |
| 03/28/2000 | US6043023 Fractionating extract of non-human model on an affinity resin column comprising anhydrotrypsin or inactive carboxypeptidase e bound to the solid support, eluting fraction containing enzyme substrate, purifying and identifying substrate |
| 03/28/2000 | US6042824 Combining the substrate and a crosslinked enzyme crystal formulation containing a crosslinked enzyme and a surfactant which acts upon the substrate in presence of organic solvent or aqueous-organic solvent to form a product |
| 03/28/2000 | US6042714 Method and chemical sensor for determining concentrations of hydrogen peroxide and its precursor in a liquid |
| 03/28/2000 | CA2270334A1 Diagnostics based on tetrazolium compounds |
| 03/28/2000 | CA2265201A1 Diagnostics based on tetrazolium compounds |
| 03/28/2000 | CA2245903A1 Use of pex in the treatment of metabolic bone diseases |
| 03/28/2000 | CA2088683C Homogenous assay system |
| 03/23/2000 | WO2000016231A1 Method for screening and producing compound libraries |
| 03/23/2000 | WO2000016101A2 Target analyte sensors utilizing microspheres |
| 03/23/2000 | WO2000016098A1 Composite devices incorporating biological material and methods |
| 03/23/2000 | WO2000016089A2 Signal detection techniques for the detection of analytes |
| 03/23/2000 | WO2000016087A1 Spectral calibration of fluorescent polynucleotide separation apparatus |
| 03/23/2000 | WO2000016082A1 Device comprising a plurality of analysis sites on a support |
| 03/23/2000 | WO2000016062A2 Methods for determining the activity of complex mixtures |
| 03/23/2000 | WO2000015852A1 Selective aflp primers for reduction of complexity of marker genotyping and dna markers for loblolly pine |
| 03/23/2000 | WO2000015851A1 Geometrical and hierarchical classification based on gene expression |
| 03/23/2000 | WO2000015850A1 Assays for measuring nucleic acid binding proteins and enzyme activities |
| 03/23/2000 | WO2000015849A1 Artificial long terminal repeat vectors |
| 03/23/2000 | WO2000015848A1 Nucleic acid ligand interaction assays |
| 03/23/2000 | WO2000015847A2 Genomic knowledge discovery |
| 03/23/2000 | WO2000015845A1 T-type calcium channel |
| 03/23/2000 | WO2000015844A1 Nucleic acid sequencing with solid phase capturable terminators |
| 03/23/2000 | WO2000015842A1 Method of isolation primer extension products with modular oligonucleotides |
| 03/23/2000 | WO2000015841A1 Method and kit for detecting intrachromosome imbalance in inter phase nuclei and their applications |
| 03/23/2000 | WO2000015840A1 Method for determining susceptibility to heart disease by screening polymorphisms in the vitamin d receptor gene |
| 03/23/2000 | WO2000015839A1 Method for determining susceptibility to bone damage by screening polymorphisms in the vitamin d receptor gene |
| 03/23/2000 | WO2000015838A2 Essential genes from c. albicans and a method for screening antimycotic substances using said genes |
| 03/23/2000 | WO2000015837A2 Method for controlling quality in the construction of oligomer grids |
| 03/23/2000 | WO2000015836A2 Combination of markers at the estrogen- and vitamin d-receptor genes or equivalents thereof to prognose a response to osteoporosis therapy |
| 03/23/2000 | WO2000015835A2 Marker at the vitamin d receptor gene for determining breast cancer susceptibility |
| 03/23/2000 | WO2000015834A2 Marker at the androgen receptor gene for determining breast cancer susceptibility |
| 03/23/2000 | WO2000015833A1 Multiple sequencing method |
| 03/23/2000 | WO2000015832A1 Detection of cells in a liquid sample |
| 03/23/2000 | WO2000015826A2 Leptin induced genes |
| 03/23/2000 | WO2000015821A1 Recombinant adenovirus for tissue specific expression in heart |
| 03/23/2000 | WO2000015816A2 Maize replication protein a |
| 03/23/2000 | WO2000015809A2 Uracil permease from arabidopsis as herbicidal target gene |
| 03/23/2000 | WO2000015806A1 Atp synthase subunit homolog |
| 03/23/2000 | WO2000015802A1 Moraxella catarrhalis basb034 polypeptides and uses thereof |
| 03/23/2000 | WO2000015801A1 Polynucleotides and polypeptides basb033 from neisseria meningitidis and their uses |
| 03/23/2000 | WO2000015797A2 Compositions and methods for the treatment of immune related diseases |
| 03/23/2000 | WO2000015794A1 Human cell junction pdz protein |
| 03/23/2000 | WO2000015793A2 Human gpcr proteins |
| 03/23/2000 | WO2000015792A2 Promotion or inhibition of angiogenesis and cardiovascularization |
| 03/23/2000 | WO2000015790A2 Leptin induced genes |
| 03/23/2000 | WO2000015788A2 Dna sequence encoding oncofetal ferritin protein |
| 03/23/2000 | WO2000015787A1 Genes encoding for the human and murine death inducer-obliterator-1 |
| 03/23/2000 | WO2000015786A1 Metabotropic gaba receptor complex issued from the central nervous system |
| 03/23/2000 | WO2000015785A2 GENE MODIFICATION IN THE GENE FOR THE DIE Gβ3-SUB-UNIT OF HUMAN G-PROTEIN |
| 03/23/2000 | WO2000015784A2 Human and murine g-protein-coupled edg6 receptor (endothelial differentiation gene) and use of same |
| 03/23/2000 | WO2000015782A1 Ribosomal frameshift targets |
| 03/23/2000 | WO2000015780A1 Inhibitor of brn-3b and its use for the treatment of breast and ovarian cancer |
| 03/23/2000 | WO2000015779A2 Molecular cloning using rolling circle amplification |
| 03/23/2000 | WO2000015777A1 Gene and protein libraries and methods relating thereto |
| 03/23/2000 | WO2000015776A1 Product and method for separation of a sample containing multiple sources of genetic material using a solid medium |
| 03/23/2000 | WO2000015775A1 Rnase p polypeptides |
| 03/23/2000 | WO2000015770A2 Human serine/threonine protein kinases |
| 03/23/2000 | WO2000015769A1 Topa |
| 03/23/2000 | WO2000015666A2 Compositions and methods for the treatment of tumors |
| 03/23/2000 | WO2000015659A2 Stomach polypeptide zsig28 |
| 03/23/2000 | WO2000015650A1 Polynucleotide and polypeptide sequences encoding rat mdr1a and screening methods thereof |
| 03/23/2000 | WO2000015618A1 Xanthan-ester and acridan substrates for horseradish peroxidase |
| 03/23/2000 | WO2000015242A1 REGULATION OF HER2/neu ONCOGENE EXPRESSION BY SYNTHETIC POLYAMIDES |
| 03/23/2000 | WO2000015209A2 REGULATION OF HER2/neu ONCONGENE EXPRESSION BY SYNTHETIC POLYAMIDES |
| 03/23/2000 | WO2000015178A2 Computer implemented pharmacokinetics method and program |
| 03/23/2000 | WO2000015097A2 Methods for using resonant acoustic energy to detect or effect structures |